This inventor holds 1 USPTO granted patent and 6 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignee: Irm LLC. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Nanxin Li
Introduction
Nanxin Li is a prominent inventor based in San Diego, California. He has made significant contributions to the field of medicine, particularly in the development of treatments for cancer. His work focuses on innovative methods that utilize ALK inhibitors to address specific medical conditions.
Latest Patents
Nanxin Li holds a patent for "Methods of using ALK inhibitors." This invention provides methods for using compounds of Formula (I) for treating an EML4-ALK-mediated condition, such as EML4-ALK non-small cell lung cancer, which may be resistant to crizotinib. This patent highlights his commitment to advancing cancer treatment options.
Career Highlights
Throughout his career, Nanxin Li has worked with notable companies, including Irm LLC and Novartis AG. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Nanxin Li has collaborated with several professionals, including Jennifer Harris and Peter McNamara. These partnerships have played a crucial role in enhancing his research and expanding the impact of his inventions.
Conclusion
Nanxin Li's innovative work in the field of cancer treatment exemplifies the importance of research and development in medicine. His contributions continue to pave the way for new therapeutic approaches that can significantly improve patient outcomes.